• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

7例尼曼-匹克C型病患者的临床表现及分子遗传学:一个包含新变异的病例系列

Clinical manifestations and molecular genetics of seven patients with Niemann-Pick type-C: a case series with a novel variant.

作者信息

Kara Cemre, Köse Engin, Eminoğlu Fatma Tuba

机构信息

Department of Pediatrics, Ankara University Faculty of Medicine, Ankara, Türkiye.

Department of Pediatric Metabolism and Ankara University Rare Diseases Application and Research Center, Ankara University Faculty of Medicine, Ankara, Türkiye.

出版信息

J Pediatr Endocrinol Metab. 2025 Jan 10;38(5):539-545. doi: 10.1515/jpem-2024-0530. Print 2025 May 26.

DOI:10.1515/jpem-2024-0530
PMID:39789920
Abstract

OBJECTIVES

Niemann-Pick type C (NPC) is a rare, autosomal recessive, neurodegenerative disorder caused by biallelic pathogenic variants in the or genes, leading to lysosomal lipid accumulation. NPC has an incidence of 1 in 100,000 live births and presents with a wide range of symptoms affecting visceral organs and the central nervous system. We aim to describe the diverse clinical presentations of NPC through case studies.

CASE PRESENTATION

We report seven NPC patients from five families, showcasing the variability in clinical manifestations. The most common finding was hepatosplenomegaly (70 %), followed by prolonged jaundice (57 %) and neonatal cholestasis. Pulmonary alveolar proteinosis (PAP) was observed in three patients with biallelic pathogenic variants in the gene. Neurological symptoms, including vertical gaze palsy and epilepsy, were noted in patients with juvenile onset form. Genetic analyses identified a novel homozygous c.315del (p.Thr106ProfsTer5) variant in the gene, associated with early infantile onset.

CONCLUSIONS

NPC presents with diverse clinical findings across ages. Early hepatic symptoms in infants and neuropsychiatric issues in older patients warrant a high index of suspicion for NPC in such cases. A multidisciplinary approach is crucial for patient management, and further research is needed to clarify genotype-phenotype relationships in NPC.

摘要

目的

尼曼-匹克C型(NPC)是一种罕见的常染色体隐性神经退行性疾病,由NPC1或NPC2基因的双等位基因致病性变异引起,导致溶酶体脂质蓄积。NPC的发病率为每10万活产中有1例,表现出影响内脏器官和中枢神经系统的广泛症状。我们旨在通过病例研究描述NPC的多种临床表现。

病例报告

我们报告了来自五个家庭的7例NPC患者,展示了临床表现的变异性。最常见的发现是肝脾肿大(70%),其次是长期黄疸(57%)和新生儿胆汁淤积。在3例NPC2基因双等位基因致病性变异的患者中观察到肺泡蛋白沉积症(PAP)。青少年发病型患者出现神经症状,包括垂直凝视麻痹和癫痫。基因分析在NPC1基因中鉴定出一种新的纯合c.315del(p.Thr106ProfsTer5)变异,与早发型婴儿型相关。

结论

NPC在各年龄段均有不同的临床表现。婴儿期的早期肝脏症状和老年患者的神经精神问题在此类病例中需要高度怀疑NPC。多学科方法对患者管理至关重要,需要进一步研究以阐明NPC的基因型-表型关系。

相似文献

1
Clinical manifestations and molecular genetics of seven patients with Niemann-Pick type-C: a case series with a novel variant.7例尼曼-匹克C型病患者的临床表现及分子遗传学:一个包含新变异的病例系列
J Pediatr Endocrinol Metab. 2025 Jan 10;38(5):539-545. doi: 10.1515/jpem-2024-0530. Print 2025 May 26.
2
Niemann-Pick Disease Type C尼曼-匹克病C型
3
High incidence of unrecognized visceral/neurological late-onset Niemann-Pick disease, type C1, predicted by analysis of massively parallel sequencing data sets.通过对大规模平行测序数据集的分析预测,未被识别的C1型尼曼-匹克病内脏/神经迟发性发病率高。
Genet Med. 2016 Jan;18(1):41-8. doi: 10.1038/gim.2015.25. Epub 2015 Mar 12.
4
Disease-Modifying, Neuroprotective Effect of N-Acetyl-l-Leucine in Adult and Pediatric Patients With Niemann-Pick Disease Type C.N-乙酰-L-亮氨酸对成年和儿童C型尼曼-匹克病患者的疾病修饰性神经保护作用
Neurology. 2025 Jul;105(1):e213589. doi: 10.1212/WNL.0000000000213589. Epub 2025 Jun 13.
5
Niemann-Pick disease type C in Palestine: genotype and phenotype of sixteen patients and report of a novel mutation in the NPC1 gene.巴勒斯坦的尼曼-匹克病 C 型:16 例患者的基因型和表型及 NPC1 基因突变的报道。
BMC Med Genomics. 2021 Sep 17;14(1):228. doi: 10.1186/s12920-021-01072-0.
6
Long-term efficacy and safety of arimoclomol in Niemann-Pick disease type C: Final results of the phase 2/3 NPC-002 48-month open-label extension trial.阿利克仑莫在C型尼曼-匹克病中的长期疗效和安全性:2/3期NPC-002 48个月开放标签扩展试验的最终结果
Mol Genet Metab. 2025 Aug;145(4):109189. doi: 10.1016/j.ymgme.2025.109189. Epub 2025 Jul 7.
7
Clinical, laboratory and molecular features of glycogen storage disease type 1a and 1b patients from Turkey: novel mutations and phenotypes.来自土耳其的1a型和1b型糖原贮积病患者的临床、实验室及分子特征:新突变与表型
Eur J Pediatr. 2025 Aug 9;184(9):540. doi: 10.1007/s00431-025-06371-7.
8
Myeloid cell-specific loss of NPC1 in mice recapitulates microgliosis and neurodegeneration in patients with Niemann-Pick type C disease.小鼠骨髓细胞特异性NPC1缺失重现了尼曼-匹克C型病患者的小胶质细胞增生和神经退行性变。
Sci Transl Med. 2024 Dec 4;16(776):eadl4616. doi: 10.1126/scitranslmed.adl4616.
9
Clinical and Molecular Features of Early Infantile Niemann Pick Type C Disease.早婴儿型尼曼-匹克病 C 型的临床和分子特征。
Int J Mol Sci. 2020 Jul 17;21(14):5059. doi: 10.3390/ijms21145059.
10
-Related Disorders-相关疾病

本文引用的文献

1
Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann-Pick disease types A, B and A/B).酸性鞘磷脂酶缺乏症(尼曼-匹克病 A、B 和 A/B 型)的共识临床管理指南。
Orphanet J Rare Dis. 2023 Apr 17;18(1):85. doi: 10.1186/s13023-023-02686-6.
2
A Niemann-Pick Disease Type C2 with Severe Pulmonary Involvement and Limited Therapeutic Options: A Case Report.一例伴有严重肺部受累且治疗选择有限的C2型尼曼-匹克病:病例报告
Children (Basel). 2022 Nov 24;9(12):1811. doi: 10.3390/children9121811.
3
Probable Miglustat-Induced Psychosis in a Child With Niemann-Pick Type C.
尼曼-皮克 C 型病患儿疑似米格列奈特引起的精神病。
Clin Neuropharmacol. 2022;45(4):107-109. doi: 10.1097/WNF.0000000000000511. Epub 2022 Jun 11.
4
Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry.尼曼-匹克病 C 型患者连续接受米格列奈治疗的治疗结果:NPC 登记处的最终报告。
Orphanet J Rare Dis. 2020 Apr 25;15(1):104. doi: 10.1186/s13023-020-01363-2.
5
VarSome: the human genomic variant search engine.VarSome:人类基因组变异搜索引擎。
Bioinformatics. 2019 Jun 1;35(11):1978-1980. doi: 10.1093/bioinformatics/bty897.
6
Miglustat in Niemann-Pick disease type C patients: a review.尼曼-匹克病 C 型患者的米格列醇治疗:综述。
Orphanet J Rare Dis. 2018 Aug 15;13(1):140. doi: 10.1186/s13023-018-0844-0.
7
Long-term therapy with miglustat and cognitive decline in the adult form of Niemann-Pick disease type C: a case report.米格列奈特长期治疗成年型尼曼-匹克病 C 型伴认知功能下降:病例报告。
Neurol Sci. 2018 Jun;39(6):1015-1019. doi: 10.1007/s10072-018-3314-5. Epub 2018 Mar 13.
8
Long-Term Treatment of Niemann-Pick Type C1 Disease With Intrathecal 2-Hydroxypropyl-β-Cyclodextrin.鞘内注射 2-羟丙基-β-环糊精治疗尼曼-匹克 C1 型病的长期疗效。
Pediatr Neurol. 2018 Mar;80:24-34. doi: 10.1016/j.pediatrneurol.2017.12.014. Epub 2018 Jan 8.
9
Psychiatric and neurological symptoms in patients with Niemann-Pick disease type C (NP-C): Findings from the International NPC Registry.尼曼-匹克病 C 型(NP-C)患者的精神神经症状:国际 NP-C 注册研究结果。
World J Biol Psychiatry. 2019 Apr;20(4):310-319. doi: 10.1080/15622975.2017.1379610. Epub 2017 Oct 9.
10
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial.鞘内注射 2-羟丙基-β-环糊精可降低尼曼-匹克病 C1 型的神经病变进展:一项非随机、开放标签、1-2 期临床试验。
Lancet. 2017 Oct 14;390(10104):1758-1768. doi: 10.1016/S0140-6736(17)31465-4. Epub 2017 Aug 10.